BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16144325)

  • 1. [Influence of water-soluble additives on drug release kinetics from biodegradable poly(lactic-co-glycolic acid) matrix].
    Song LP; Yang J; Wang H; Sun HF; Tang LN; Wu L; Chang J; Song CX
    Yao Xue Xue Bao; 2005 Jun; 40(6):557-62. PubMed ID: 16144325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model.
    Song C; Labhasetwar V; Cui X; Underwood T; Levy RJ
    J Control Release; 1998 Jul; 54(2):201-11. PubMed ID: 9724907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Poly(Diol Sebacate)s as Additives to Modify Paclitaxel Release From Poly(Lactic-co-Glycolic Acid) Thin Films.
    Navarro L; Mogosanu DE; Ceaglio N; Luna J; Dubruel P; Rintoul I
    J Pharm Sci; 2017 Aug; 106(8):2106-2114. PubMed ID: 28535975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug type on the degradation rate of PLGA matrices.
    Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
    Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
    Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico mechanistic disposition and in vivo evaluation of zero-order drug release from a novel triple-layered tablet matrix.
    Moodley K; Choonara YE; Kumar P; du Toit LC; Pillay V
    Expert Opin Drug Deliv; 2015 May; 12(5):693-713. PubMed ID: 25534542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
    Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; BenoƮt JP; Montero-Menei CN; Venier-Julienne MC
    Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
    Lee JB; Chun KW; Yoon JJ; Park TG
    Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of additives on the release of a model protein from PLGA microspheres.
    Kang F; Singh J
    AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
    Wang N; Wu XS
    J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK; Chung HJ; Park TG
    J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
    Nandakumar V; Geetha V; Chittaranjan S; Doble M
    Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
    Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
    Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
    Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
    J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.